Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Acutus Medical Inc (AFIB)

17   -0.81 (-4.55%) 03-07 03:49
Open: 17.86 Pre. Close: 17.81
High: 17.86 Low: 15.58
Volume: 829,868 Market Cap: 473M
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. It offers AcQMap console and workstation, an advanced imaging, navigation, and mapping system for physicians to map, treat, re-map, and adjust additional therapy as needed; and Patient Electrode Kit that is required in every procedure to provide cardiac signals, catheter localization, and AcQMap system grounding. The company also provides diagnostic and monitoring devices, such as AcQMap 3D Imaging and Mapping Catheter that is used for mapping during the electrophysiology procedures; conventional diagnostic catheters, including multi-polar, steerable, and loop catheters that are used during the mapping and ablation procedures; and reprocessed diagnostic catheters, such as diagnostic, multipole, fixed, steerable, and advanced mapping and imaging catheters. In addition, the company provides access devices, which include AcQRef Introducer that provides stable electrical reference and vascular access; AcQGuide MAX Steerable Introducer, which provides a stable platform for catheter passage and precision placement; and Transseptal Access Products. Further, it offers therapeutic devices, such as AcQBlate FORCE Ablation Catheters, AlCath Ablation Catheters, MedFact Robotic Navigation Enabled Ablation Catheters, Qubic Force, Qubic RF Generator and Pulse Stimulator, and Qiona Pump. The company also provides various software mapping modes comprises single position, supermap, contact mapping, and stereotaxis integration. Acutus Medical, Inc. was founded in 2011 and is based in Carlsbad, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.887 - 18.012 18.012 - 18.108
Low: 15.288 - 15.439 15.439 - 15.556
Close: 16.773 - 16.995 16.995 - 17.165

Technical analysis

as of: 2021-03-05 5:04:41 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 27.64     One year: 33.47
Support: Support1: 15.58    Support2: 12.96
Resistance: Resistance1: 23.66    Resistance2: 28.66
Pivot: 21.62
Moving Average: MA(5): 19.30     MA(20): 22.29
MA(100): 26.27     MA(250):
MACD: MACD(12,26): -2.05     Signal(9): -1.62
Stochastic oscillator: %K(14,3): 7.19     %D(3): 10.88
RSI: RSI(14): 21.00
52-week: High: 38.99  Low: 15.58  Change(%): -35.8
Average Vol(K): 3-Month: 25571  10-Days: 33955

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AFIB has closed below the lower band by 3.3%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 43% wider than normal. The large width of the bands suggest high volatility as compared to AFIB's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Thu, 04 Mar 2021
Acutus Medical to Announce Fourth Quarter and Full Year 2020 Financial Results - Stockhouse

Wed, 03 Mar 2021
$2.52 Million in Sales Expected for Acutus Medical, Inc. (NASDAQ:AFIB) This Quarter - MarketBeat

Tue, 02 Mar 2021
Acutus Medical Receives Vizient Innovative Technology Contract - GlobeNewswire

Wed, 17 Feb 2021
Index Venture Associates V Ltd Buys Acutus Medical Inc, Sells Farfetch - Yahoo Finance

Tue, 09 Feb 2021
Acutus Medical, Inc. Appoints New Chief Financial Officer and New Board Member - GlobeNewswire

Thu, 28 Jan 2021
Acutus Medical Suite of EP Products To Be Featured During Recorded Cases at AF Symposium 2021 - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 28
Shares Float (M) 15
% Held by Insiders 2.26
% Held by Institutions 88.83
Shares Short (K) 2,010
Shares Short P. Month (K) 2,570

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -1245.28
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 391.2
Gross Profit (p.s.) -0.230
Sales Per Share 0.236
EBITDA (p.s.) -2.838
Qtrly Earnings Growth
Operating Cash Flow (M) -86
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 72.17
Price to Cash Flow -5.49

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.